GlassScriptPhysician profile
Clinton Mallari
NPI 1154345585
$1,457.82
in general payments reported to CMS, 2019-2025
9 companies · $380 in 2025
The $380 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $284 · 2021: $256 · 2022: $172 · 2023: $45.08 · 2024: $37.99 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $911.38 | 2019-2025 | Eterna, Proclaim |
| Spinefrontier, INC. | $362.66 | 2025 | Inspan, Facetfuse, Sijfuse |
| Medtronic USA, INC. | $48.31 | 2019 | |
| Pfizer INC. | $42.66 | 2019-2021 | |
| Tersera Therapeutics LLC | $25.04 | 2019 | |
| Biodelivery Sciences International, INC. | $21.45 | 2020 | |
| Collegium Pharmaceutical, INC. | $18.85 | 2021 | |
| Pernix Therapeutics Holdings, INC. | $16.08 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Mallari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.